Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-Year follow up in 10 patients

Journal of Neurosurgery

Volumn 86, Issue 6, 1997, Pages 931-942

  López Lozano, Juan J ^a   Bravo, Gonzalo ^b   Brera, Begoña ^b   Millán, Isabel ^b   Dargallo, Jose ^b   Salmeán, Javier ^b   Uría, Jose ^b   Insausti, Jose ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b NONE

Author keywords

dopamine; embryonic graft; neurotrophic; Parkinson's disease; substantia nigra; transplantation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TRANSPLANTATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MESENCEPHALON; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TREATMENT OUTCOME;

EID: 1842369693     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.6.0931     Document Type: Article

References (67)

1. Ahlskog JE: Cerebral transplantation for Parkinson's disease: current progress and future prospects. Mayo Clin Proc 68: 578-591, 1993
2. Bankiewicz KS, Plunkett RJ, Jakobowitz DM, et al: The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg 72:231-244, 1990
3. Bankiewicz KS, Plunkett RJ, Mefford I, et al: Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites. Progr Brain Res 82:561-571, 1990
4. Björklund A: Dopaminergic transplants in experimental parkinsonism: cellular mechanism of graft-induced functional recovery. Curr Opin Neurobiol 2:683-689, 1992
5. Björklund A, Stenevi U (eds): Neural Grafting in the Mammalian CNS. Amsterdam: Elsevier, 1985
6. Blunt SB, Jenner P, Marsden CD: Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov Disord 8:129-133, 1993
7. Bohn MC, Cupit L, Marciano F, et al: Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913-916, 1987
8. De Felipe J, Jones EG: Cajal's Degeneration and Regeneration of the Nervous System. New York: Oxford University Press, 1991
9. Dunnett SB: Transplantation of embryonic dopamine neurons: what we know from rats. J Neurol 238:65-74, 1991
10. Dunnett SB, Annett LE: Nigral transplants in primate models of parkinsonism, in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Experimental Basis and Clinical Experiences. Amsterdam: Elsevier, 1991, pp 27-51
11. Fiandaca MS, Bakay RA, Sweeney KM, et al: Immunologic response to intracerebral fetal neural allografts in the rhesus monkey. Prog Brain Res 78:287-296, 1988
12. Finklestein SP, Apostolides PJ, Caday CG, et al: Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res 460:253-259, 1988
13. Freed CR, Breeze RE, Rosenberg NL, et al: Immunosuppressants may not improve transplant success after human fetal dopamine cell implants for Parkinson's disease. Neurology 44 (Suppl 2):323, 1994 (Abstract)
14. Freed CR, Breeze RE, Rosenberg NL, et al: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555, 1992
15. Freed CR, Breeze RE, Rosenberg NL, et al: Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol 47:505-512, 1990
16. Freed WJ: Neural transplantation: prospects for clinical use. Cell Transplant 2:13-31, 1993
17. Freed WJ: Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. Restor Neurol Neurosci 3:109-134, 1991
18. Freeman T, Hauser R, Sanberg P, et al: Fetal transplantation in Parkinson's disease. Neurology 44 (Suppl 2):A324, 1994 (Abstract)
19. Henderson BT, Clough CG, Hughes RC, et al: Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 48:822-827, 1991
20. Hitchcock ER, Henderson BTH, Kenny BG, et al: Stereotactic implantation of foetal mesencephalon, in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Experimental Basis and Clinical Experiences. Amsterdam: Elsevier, 1991, pp 79-86
21. Hitchcock ER, Kenny BG, Clough CG, et al: Stereotactic implantation of fetal mesencephalon. Stereotact Funct Neurosurg 54/55:282-289, 1990
22. Hitchcock ER, Kenny BG, Clough CG, et al: Stereotactic implantation of foetal mesencephalon (STIM): the UK experience. Prog Brain Res 82:723-728, 1990
23. Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 17:427-442, 1967
24. Hunter KR, Shaw KM: The Clinical Use of Levodopa Therapeutics Effects. Baltimore: University Park, 1975, pp 47-51
25. Iacono RP, Tang ZS, Mazziotta JC, et al: Bilateral fetal grafts for Parkinson's disease: 22 months' results. Stereotact Funct Neurosurg 58:84-87, 1992
26. Jacques DB, Kopyov OV, Markham CH, et al: One-year follow-up of six Parkinson's patients with fetal ventral mesencephalon grafts. Neurology 44 (Suppl 2):A323, 1994 (Abstract)
27. Koller WC (ed): Handbook of Parkinson's Disease, ed 2. New York: Marcel Dekker, 1992
28. Kordower JH, Cochran E, Penn RD, et al: Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol 29:405-412, 1991
29. Kordower JH, Felten DL, Gash DM: Neural grafting for Parkinson's disease, in Olanow CW, Lieberman AN (eds): The Scientific Basis for the Treatment of Parkinson's Disease. Park Ridge, NJ: Parthenon, 1992, pp 175-224
30. Kordower JH, Freeman TB, Snow BJ, et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:118-124, 1995
31. Langston JW, Widner H, Goetz CG: Core assessment program for intracerebral transplantation (CAPIT). Mov Disord 7: 2-13, 1992
32. LEY 42, de 28 de diciembre: De donación y utilización de embriones y fetos humanos o de sus células, tejidos u órganos. BOE 314:36766-36767, 1988
33. Lindvall O, Björklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Experimental Basis and Clinical Experiences. Amsterdam: Elsevier, 1991
34. Lindvall O, Rehncrona S, Brundin P, et al: Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 46:615-631, 1989
35. Lindvall O, Sawle G, Widner H, et al: Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:172-180, 1994
36. Lindvall O, Widner H, Rehncrona S, et al: Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 31:155-165, 1992
37. López-Lozano JJ, Abascal J, Bravo G, et al: A year follow-up of autoimplants of perfused adrenal medulla into parkinsonian patients. Prog Brain Res 82:657-663, 1990
38. López-Lozano JJ, Bravo G, Abascal J, et al: Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. Lancet 339:430, 1992
39. López-Lozano JJ, Bravo G, Abascal J, et al: Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. J Neurosurg 75:234-243, 1991
40. López-Lozano JJ, Bravo G, Abascal J, et al: A long-term study of Parkinson's patients subjected to autoimplants of perfused adrenal medulla into the caudate nucleus. Transplant Proc 22: 2243-2246, 1990
41. López-Lozano JJ, Bravo G, Brera B, et al: Can an analogy be drawn between the clinical evolution of Parkinson's patients who undergo autoimplantation of adrenal medulla and those of fetal ventral mesencephalon recipients? in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Experimental Basis and Clinical Experiences. Amsterdam: Elsevier, 1991, pp 87-98
42. López-Lozano JJ, Brera B: Neural transplants in Parkinson's disease. CPH Neural Transplantation Group. Transplant Proc 25:1005-1011, 1993
43. López-Lozano JJ, Notter MFD, Gash DM, et al: Selective flow cytometric sorting of viable dopamine neurons. Brain Res 486: 351-356, 1989
44. Madrazo I, Drucker-Collin R. Díaz V, et al: Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 316:831-834, 1987
45. Madrazo I, Franco-Bourland R, Aguilera M, et al: Fetal ventral mesencephalon brain homotransplantation in Parkinson's disease: the Mexican experience, in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Experimental Basis and Clinical Experiences. Amsterdam: Elsevier, 1991, pp 123-130
46. Madrazo I, Franco-Bourland R, Ostrosky-Solis F, et al: Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects. Arch Neurol 47: 1281-1285, 1990
47. Meyers R: Surgical experiments in the therapy of certain "extra-pyramidal" diseases: current evaluation. Acta Psychiatr Neurol 67 (Suppl):31-42, 1951
48. Molina H, Galarraga J, Quiñones R, et al: El Neurotrasplante en la Enfermedad de Parkinson. Experiencia Cubana. Reporte Preliminar. Ciudad Habana: Centro de Trasplante y Regeneración del Sistema Nervioso, 1988, p 18
49. Molina H, Quinones R, Alvarez L, et al: Transplantation of human mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: the Cuban experience. Restor Neurol 4: 99-110, 1991
50. Otto D, Unsicker K: Basic FGF reverses chemical and morpholooical deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10:1912-1921, 1990
51. Patino P, Kriek EH, Hutt CJ, et al: Short term corticosteroid treatment impairs survival of fetal dopamine cell transplanted into a rat model of Parkinson's disease. Soc Neurosci Abstr 18:59, 1992 (Abstract)
52. Peschanski M, Defer G, N'Guyen JP, et al: Bilateral motor improvement and alteration of L-DOPA effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499, 1994
53. Plunkett RJ, Bankiewicz KS, Cummins AC, et al: Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. J Neurosurg 73:918-926, 1990
54. Redmond DE, Robbins RJ, Naftolin F, et al: Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients, in Waxman SG (ed): Molecular and Cellular Approaches to the Treatment of Neurological Disease. New York: Raven Press, 1993, pp 325-359
55. Redmond DE, Sladek JR Jr, Roth RH, et al: Foetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1:1125-1127, 1986
56. Sladek JR Jr, Redmond DE Jr, Collier TJ, et al: Foetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 78:497-506, 1988
57. Slotkin TA, Lappi SE, McCook EC, et al: Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate 61:326-336, 1992
58. Spencer DD, Robbins RJ, Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548, 1992
59. Steece-Collier K, Collier TJ, Sladek CD, et al: Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Exp Neurol 110:201-208, 1990
60. Strömberg I, van Home C, Bygdeman M, et al: Function of intraventricular human mesencephalic xenografts in immunosuppressed rats: an electrophysiological and neurochemical analysis. Exp Neurol 112:140-152, 1991
61. Subrt O, Tichy M, Vladyka V, et al: Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients. Acta Neurochir Suppl 52:51-53, 1991
62. Tello F: La influencia del neurotropismo en la regeneración de los centros nerviosos. Trab Lab Invest Biol 9:123-159, 1911
63. Venna N, Sabin TD, Ordia JI, et al: Treatment of severe Parkinson's disease by intraventricular injection of dopamine. Appl Neurophysiol 47:62-64, 1984
64. Widner H, Tetrud J, Rehncrona S, et al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563, 1992
65. Yahr MD, Duvoisin RC, Schear MJ, et al: Treatment of parkinsonism with levodopa. Arch Neurol 21:343-354, 1969
66. Yurek DM, Sladek JR Jr: Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci 13:415-440, 1990
67. Zabek M, Mazurowski W, Dymecki J, et al: [Transplantation of fetal dopaminergic cells in Parkinson's disease.] Neurol Neurochir Pol 13 (Suppl 1):13-19, 1992 (Pol)